skip to main content

Metronidazole Resistance — SCE Dermatology MCQ

Instant feedback + full explanation. One question, done properly.

EasyInflammatory DermatosesMetronidazole ResistanceSCE Dermatology

A 55-year-old woman with rosacea on long-term topical Metronidazole asks about resistance. Does Metronidazole resistance develop with long-term topical use?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: A — No — topical Metronidazole does not promote clinically significant antimicrobial resistance because its mechanism in rosacea is primarily anti-inflammatory rather than antimicrobial

Topical Metronidazole for rosacea works primarily through anti-inflammatory mechanisms (inhibiting ROS generation, reducing neutrophil migration) rather than antimicrobial activity against skin flora. Therefore, prolonged use does not promote clinically significant antimicrobial resistance — unlike topical antibiotics used for acne (Erythromycin, Clindamycin) where resistance is a major concern. Topical Metronidazole can be safely used long-term for rosacea maintenance without resistance concerns. It should be applied once or twice daily. Alternative topical agents include Azelaic acid 15% (anti-inflammatory + keratolytic) and Ivermectin 1% (anti-Demodex + anti-inflammatory). Topical Brimonidine addresses erythema specifically but not papulopustules.

Reference: BAD 2021 Rosacea; NICE